Feed morbidity-and-mortality-weekly-report-mmwr Morbidity and Mortality Weekly Report (MMWR)

Favorite IconMorbidity and Mortality Weekly Report (MMWR)

Link https://www.cdc.gov/mmwr/index.html
Feed http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Updated 2025-04-08 23:31
Notes from the Field: Response to a Case of Travel-Associated Lassa Fever — Iowa, October–November 2024
This report describes a fatal Lassa fever case in a patient returning form Liberia.
Epidemiology of Symptomatic Human Metapneumovirus Infection in the CASCADIA Community-Based Cohort — Oregon and Washington, 2022–2024
This report describes a community cohort study on the average incidence of symptomatic human metapneumovirus infection in Oregon and Washington.
Human Metapneumovirus Seasonality and Co-Circulation with Respiratory Syncytial Virus — United States, 2014–2024
This report describes co-circulation of human metapneumovirus and respiratory syncytial virus.
<em>Notes from the Field</em>: Fatal <em>Acanthamoeba</em> Encephalitis in a Patient Who Regularly Used Tap Water in an Electronic Nasal Irrigation Device and a Continuous Posi
This report describes a fatal case of Acanthamoeba infection associated with using tap water in an electronic nasal irrigation device and a CPAP machine at home.
Synthetic Opioid and Stimulant Co-Involved Overdose Deaths by Occupation and Industry — United States, 2022
This report describes an analysis of synthetic opioid and stimulant co-involved overdose deaths by occupations and industries.
Fatal Case of Splash Pad–Associated <em>Naegleria fowleri</em> Meningoencephalitis — Pulaski County, Arkansas, September 2023
This report describes a fatal case of Naegleria fowleri infection associated with a splash pad in Arkansas.
Newly Reported Chronic Hepatitis C Among Adults — Alaska, 2016–2023
This report describes the annual rate of newly reported chronic hepatitis C among adults in Alaska.
Functional Disability, Violence, HIV Status, and Risk Factors for HIV Among Adolescent Girls and Young Women — Eswatini, 2022
This report describes adolescent girls and young women with functional disabilities had who higher prevalence of experiencing sexual, physical and emotional violence.
<em>Notes from the Field</em>: Rhodesiense Human African Trypanosomiasis (Sleeping Sickness) in a Traveler Returning from Zimbabwe — United States, August 2024
This report describes a case of rhodesiense human African trypanosomiasis among a U.S. traveler returning from Zimbabwe.
Case Finding Among and Comprehensive Management of Household Contacts of Persons with Pulmonary Tuberculosis: a Pilot Project — Uganda, 2023–2024
This report describes management of tuberculosis (TB) risk among household contacts of people living with TB.
<em>Notes from the Field</em>: Neurosyphilis, Ocular Syphilis, and Otic Syphilis — Chicago, January–October 2023
This report describes neurosyphilis, ocular syphilis, and otic syphilis cases in Chicago during January 1-October 31, 2023.
Human Cases of Highly Pathogenic Avian Influenza A<b>(</b>H5N1<b>)</b> — California, September–December 2024
This report describes cases of highly pathogenic avian influenza detected among 38 people in California.
Pedestrian and Overall Road Traffic Crash Deaths — United States and 27 Other High-Income Countries, 2013–2022
This report describes traffic-related deaths rates in the U.S. and 27 high-income countries.
Notes from the Field: Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater — Five European Countries, September–December 2024
This report describes vaccine-derived poliovirus type 2 detected in wastewater samples in 16 cities in five European countries.
Notes from the Field: Tobacco Product Use Among Adults — United States, 2017–2023
This report describes a decrease in the number of adults who exclusively smoke cigarettes and an increase in the number who exclusively use e-cigarettes.
Notes From the Field: Enhanced Identification of Tobacco Use Among Adult Medicaid Members — King County, Washington, 2016–2023
This report describes tobacco use among Medicaid members during 2016-2023.
Idiopathic Pulmonary Fibrosis Mortality by Industry and Occupation — United States, 2020–2022
This report describes idiopathic pulmonary fibrosis deaths among U.S. workers by industry and occupation.
QuickStats: Percentage of Adults Aged ≥18 Years with Chronic Pain in the Past 3 Months, by Sex and Urbanization Level — United States, 2023
This report describes the percentage of adults with chronic pain in the past three months.
QuickStats: Percentage Distribution of Deaths Attributed to Excessive Cold or Hypothermia, by Month — United States, 2023
This report describes deaths attributed to excessive cold or hypothermia by month.
Avian Influenza A(H5) Subtype in Wastewater — Oregon, September 15, 2021–July 11, 2024
This report describes an analysis of Oregon wastewater surveillance data that detected avian influenza A(H5) in communities with no concurrent outbreaks from dairy facilities or dairy farms.
Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022
This report describes decreases in cervical precancer incidence among women ages 20-24 years.
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025
This report describes 2024-2025 COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care encounters.
Reports of Encephalopathy Among Children with Influenza-Associated Mortality — United States, 2010–11 Through 2024–25 Influenza Seasons
This report describes cases of influenza-associated encephalopathy or encephalitis among children during 2010-11 through 2024-25 flu seasons.
Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025
This report describes interim 2024-2025 seasonal flu vaccine effectiveness estimates in outpatient settings and against flu-associated hospitalizations.
Notes from the Field: Elevated Atmospheric Lead Levels During the Los Angeles Urban Fires — California, January 2025
This report describes an increase in particulate matter lead levels in Los Angeles, California during the January 2025 fires.
Notes from the Field: Genomic and Wastewater Surveillance Data to Guide a Hepatitis A Outbreak Response — Los Angeles County, March 2024–June 2024
This report describes significant increase in hepatitis A virus (HAV) wastewater concentrations during an HAV outbreak in Los Angeles County, California.
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection of Indoor Domestic Cats Within Dairy Industry Worker Households — Michigan, May 2024
This report describes highly pathogenic avian influenza virus infection among two indoor cats living in homes of dairy workers.
Dengue Outbreak and Response — Puerto Rico, 2024
This report describes a local public health emergency triggered by dengue cases in Puerto Rico during 2024.
Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners — United States, September 2024
This report describes evidence of recent highly pathogenic avian influenza infection among three veterinary practitioners.
First Clade Ib Monkeypox Virus Infection Reported in the Americas — California, November 2024
This report describes the first reported case of clade Ib monkeypox virus infection in the United States.
Notes from the Field: Serum Concentrations of Perfluoroalkyl and Polyfluoroalkyl Substances Among First Responders to the Maui Wildfires — Hawaii, September 2023
This report describes concentrations of perfluoroalkyl and polyfluoroalkyl substances among Maui County, Hawaii employees one month after the 2023 Maui wildfires.
Notes from the Field: Emergency Department Use During the Los Angeles County Wildfires, January 2025
This report describes wildfire-associated emergency department encounters immediately after the 2025 Los Angeles County wildfires.
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2025
This report describes CDC's 2025 immunization schedule for children and adolescents aged 18 years or younger.
Gaps in Mental Health Care–Seeking Among Health Care Providers During the COVID-19 Pandemic — United States, September 2022–May 2023
This report describes barriers to health care providers seeking mental health care during the COVID-19 pandemic.
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2025
This report describes CDC's 2025 immunization schedule for adults aged 19 years and older.
QuickStats: Health Center Visit Rates, by Adults Aged ≥18 Years with Mental Health Disorder, Substance Use Disorder, or Both, by Sex — United States, 2023
This report describes health center visit rates by adults with mental health disorder, substance use disorder, or both
Notes from the Field: Severe Health Outcomes Linked to Consumption of Mushroom-Based Psychoactive Microdosing Products — Arizona, June–October 2024
This report describes cases of adverse health effects after ingestion of Diamond Shruumz-brand chocolate bars.
Occupational Exposure to Mercury at an Electronics Waste and Lamp Recycling Facility — Ohio, 2023
This report describes mercury exposures among workers at an Ohio electronics waste and lamp recycling facility.
Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
This report describes CDC's updated pneumococcal conjugate vaccine recommendation for all adults aged >=50 years who are PCV-naive or who have unknown vaccination history.
Outbreak of Blastomycosis Among Paper Mill Workers — Michigan, November 2022–May 2023
This report describes an outbreak of blastomycosis among workers at a paper mill in Michigan.
Tularemia — United States, 2011–2022
This report describes an increase in Tularemia cases in 2011-2022 compared to 2001-2010.
Notes from the Field: School-Based Surveillance of Mycoplasma pneumoniae Trends and Impact on School Attendance by Students and Staff Members — Missouri, Fall 2024
This report describes Mycoplasma pneumoniae infections among students and staff of a large public school district in Missouri.
Notes from the Field: Geo-Temporal Trends in Fentanyl Administration Routes Among Adults Reporting Use of Illegally Manufactured Fentanyl When Assessed for Substance-Use Treatment — 14 U.S. Stat
This report describes the percentage of people injecting illegally manufactured fentanyl by route of administration.
Notes from the Field: Long COVID and Significant Long COVID–Associated Activity Limitation Among Adults, by Jurisdiction — United States, 2023
This report describes adults with Long COVID and reported limitations performing daily activities.
Surveillance of Human Adenovirus Types and the Impact of the COVID-19 Pandemic on Reporting — United States, 2017–2023
This report describes a decrease in reporting of human adenoviruses cases to the National Adenovirus Type Reporting System since the COVID-19 pandemic.
QuickStats: Mental Health Treatment Trends Among Adults Aged ≥18 Years, by Age Group — United States, 2019–2023
This report describes mental health treatment trends among adults.
New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024
This report describes CDC's updated recommendations for the MenB-4C vaccine to align the dosing interval and schedule with the new FDA label.
Progress Toward Poliomyelitis Eradication — Afghanistan, January 2023–September 2024
This report describes progress towards eliminating wild poliovirus type 1 in Afghanistan.
Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committ
This report describes CDC's recommendation that all people aged >=65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.
Epidemiology of Dengue — Puerto Rico, 2010–2024
This report describes changing trends among patients with dengue in Puerto Rico.
12345678910...